Page 7 - Jon Pilcher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Neuren Pharmaceuticals is Karst Peak and Milford Asset Management s top biotech pick

Neuren Pharmaceuticals’ share price has almost doubled in six months, but investors think it’s still undervalued as it approaches its first FDA approval.

New south walesJon pilcherPitt hopkinsAuckland universityDrug administrationUs armyKarst peak capitalKarst peakMilford asset managementWill curtayne

Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial

Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Jon pilcherPitt hopkinsNeuren pharmaceuticalsInvestigational new drug

Neuren receives ethics approval for Angelman Phase 2 trial

Neuren receives ethics approval for Angelman Phase 2 trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

New south walesJon pilcherHuman research ethics committeeAustin healthNeuren pharmaceuticalsQueensland childrenHealth researchSydney children

Approval for Neuren Pharmaceuticals Phase 2 trial in Angelman syndrome

Approval for Neuren Pharmaceuticals Phase 2 trial in Angelman syndrome
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Jon pilcherPitt hopkinsEthics committeeNeuren pharmaceuticalsInvestigational new drug

Neuren Pharmaceuticals (ASX:NEU) share price rockets 100% on study results

The Neuren Pharmaceuticals share price is soaring to yearly highs on the back of positive phase three clinical trial results

Jon pilcherAcadia pharmaceuticalsNeuren pharmaceuticalsNeuren pharmaceuticals ltd